Abstract

Mass vaccination has significantly reduced the incidence of pertussis, however, the disease is re-emerging, even in some countries with high vaccination coverage. In Serbia, whole cell pertussis vaccine was introduced in 1957. To monitor changes in bacterial population, 77 isolates collected from 1953 to 2011 were studied. The methods included serotyping of fimbriae (Fim), genotyping of pertactin (prn) and pertussis toxin S1 subunit (ptxA). A shift from ptxA2 to ptxA1 has been observed in isolates since the late of 1960s. In the period 1961-1979, the genotype ptxA1 became as common as genotype ptxA2. After that, during the period 1980-1989, the predominant ptx genotype was ptxA1. The reappearance of the ptxA2 allele followed an addition of the two strains harboring ptxA1 in the vaccine in 1985. The allele prn1 was predominant among the Serbian isolates, though prn3 and prn11 have been detected since 1981. The prn2 allele was only found in one strain isolated in 1984, two of the four strains isolated in 2000 and in three isolated strains from 2011. Serotype Fim2.3 disappeared before 1980 and serotype Fim2 became predominant thereafter. The results of this study indicate that the B. pertussis population in Serbia is different from other vaccinated populations and that this difference may be related to the vaccine used.

Highlights

  • Pertussis is a worldwide infectious disease caused by the bacteria Bordetella pertussis (Miller et al, 1992)

  • The aim of this study was to analyze B. pertussis isolates circulating between 1953 and 2011 in Serbia by standard typing methods (Mooi et al, 2000) and to compare them to those circulating in other European countries, USA and Australia

  • Clinical isolates were selected from the B. pertussis strain collection of the Institute of Virology, Vaccine and Sera Torlak, Belgrade, Serbia

Read more

Summary

Introduction

Pertussis (whooping cough) is a worldwide infectious disease caused by the bacteria Bordetella pertussis (Miller et al, 1992). The resurgence of pertussis in countries such as the Netherlands, the United States, Canada and Australia, has been studied to find an explanation for its re-emergence (Cassiday et al, 2000; Mattoo and Cherry, 2005; Byrne and Slack, 2006; de Greeff et al, 2010, Celentano et al, 2005). In these countries antigenic divergence with respect to pertussis toxin (Ptx) and pertactin (Prn) has been found between Bordetella pertussis vaccine strains

Objectives
Methods
Results
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.